ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft (Q46310541)
scientific article
Language:
(P31) (Q13442814)
(P304) 985-997
(P433) 6
(P478) 49
(P577) Wednesday, October 1, 2008
(P921) (Q64148587)
(Q1148337)
(Q32089)
(P1433) (Q15724402)
(P1476) "ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft" (language: en)
(P2093) Viraj J Jasinghe
Zhigang Xie
Jianbiao Zhou
Jiaying Khng
Lai-Fong Poon
Palaniyandi Senthilnathan
Keith B Glaser
Daniel H Albert
Steven K Davidsen
Chien-Shing Chen
other details
description scientific article

External Links